12 employees
GlycoSeLect specializes in the development of technology to separate glycoproteins for biopharmaceutical product analysis & manufacture.
2013
$529K
from 2 investors over 2 rounds
GlycoSeLect Ltd raised $529K on October 24, 2017
Investors: KBI Biopharma and Enterprise Ireland